Growth & Performance

CJC + IPA Blend

Name: CJC + IPA Blend
Brand: Pulse Biolabs

Research peptide blend supplied in Australia by Pulse Biolabs for laboratory use. Available in 5mg/5mg.

Catalogue blend

One vial, more than one compound. Each component has its own research note.

Labelled composition: 5 mg CJC-1295 without DAC (modified GRF 1–29) and 5 mg ipamorelin in one vial. The March 2026 independent report for batch B.4.26 identified the CJC component as the without-DAC form; assay amounts on that report are measured results for that batch, not the nominal formulation. No published study of this blend was identified; each component’s evidence is separate. Combining compounds in one vial does not add their studies together.

CJC-1295 — Pulse Research // 014
CJC-1295 is a modified copy of the active segment of growth hormone-releasing hormone (GHRH), the brain signal that tells the pituitary to release growth hormone.
Ipamorelin — Pulse Research // 010
Ipamorelin is a synthetic five-amino-acid peptide that activates the ghrelin receptor on pituitary cells, prompting a pulse of growth hormone release rather than supplying the hormone.

Why a mixture needs evidence of its own →

Available presentations

Presentation	Code	Status	Price
5mg/5mg	CI5	In stock	$110

View in store

Batch documents

3 published reports for CJC + IPA Blend, listed by presentation and batch. Where a batch reference is shown, match it to the batch on the vial label; a report for an earlier batch is historical documentation and does not describe the batch currently supplied. Where no batch reference is published, the report cannot be matched to a vial and is historical documentation only. Each report describes the sample and the tests shown on it. A purity result does not by itself establish identity, quantity, sterility or endotoxin status unless those tests appear on the report, and a report for one batch does not describe another.

Presentation	Report	Batch
5mg/5mg	manufacturer certificate	no batch reference published (internal label: Original (Undated))	Open
5mg/5mg	manufacturer certificate	B.4.26	Open
5mg/5mg	independent laboratory report	B.4.26	Open

All CJC + IPA Blend documents →

Handling

Supplied as lyophilised (freeze-dried) powder in a single sealed vial containing more than one peptide. Store sealed and protected from light at the conditions stated on the product label or supplied specification. Because the components differ in stability, solvent choice and handling after reconstitution are a matter for the laboratory’s own procedures and are not specified here.

Status and limitations

The statuses below are the components’. A finished mixture is subject both to any restriction on its components and to the requirements that apply to it as a product; neither is settled by adding the components’ statuses together.

CJC-1295: CJC-1295, with or without DAC, is not an approved medicine in Australia, and no approval elsewhere was identified. Growth hormone-releasing factors are prohibited at all times in sport under WADA category S2.
Ipamorelin: In Australia ipamorelin is a Schedule 4 (prescription only) substance under the Poisons Standard (June 2026), and listed in Appendix D (clause 5), which the states and territories apply through their own poisons legislation to restrict possession without authority; growth hormone secretagogues are also scheduled as a class. It is not an approved medicine in Australia, and no approval elsewhere was identified. Ipamorelin is named under S2.2.4 on the WADA 2026 Prohibited List, prohibited at all times.

All products supplied by Pulse Biolabs are intended strictly for laboratory and research use. They are not medicines, are not for human or veterinary consumption, and are not supplied for the diagnosis, treatment, cure or prevention of any condition. No therapeutic claims are made.